https://www.researchgate.net/profile/Gerard-Hanna
Huge gratitude to my colleagues, collaborators and friends who have supported me over the years, but huge 🙏 to Suzie and my family ❤️
@leechmmichelle.bsky.social @qubelfastofficial.bsky.social
Huge gratitude to my colleagues, collaborators and friends who have supported me over the years, but huge 🙏 to Suzie and my family ❤️
@leechmmichelle.bsky.social @qubelfastofficial.bsky.social
Beautiful today in #Newcastle Co. Down
Beautiful today in #Newcastle Co. Down
Great to discuss the optimisation of radiotherapy and how #bigdata may help
Great to discuss the optimisation of radiotherapy and how #bigdata may help
Thanks to @btog.bsky.social for 3 fantastic years in Belfast
It’s been an absolute pleasure to have the BTOG community over with us for the last 3 years 🙏
Here’s to next year in Edinburgh!
@drsanjaypopat.bsky.social
@tnewsomdavis.bsky.social
Thanks to @btog.bsky.social for 3 fantastic years in Belfast
It’s been an absolute pleasure to have the BTOG community over with us for the last 3 years 🙏
Here’s to next year in Edinburgh!
@drsanjaypopat.bsky.social
@tnewsomdavis.bsky.social
➡️ Discusses NRG005 and the better outcomes for patients reviving twice daily radiotherapy.
➡️ Continued evidence of a benefit from PCI in LS-SCLC
➡️ Discusses NRG005 and the better outcomes for patients reviving twice daily radiotherapy.
➡️ Continued evidence of a benefit from PCI in LS-SCLC
➡️ BiTE engages, ADCs and many other agents showing promise
➡️ Possible role for radioligands
➡️ New never smokers phenotype emerging
➡️ Many reasons to be hopeful!
@drjnaidoo.bsky.social
@tnewsomdavis.bsky.social
➡️ BiTE engages, ADCs and many other agents showing promise
➡️ Possible role for radioligands
➡️ New never smokers phenotype emerging
➡️ Many reasons to be hopeful!
@drjnaidoo.bsky.social
@tnewsomdavis.bsky.social
Updates the congress on the new #ESTRO guidelines in this area
@drjnaidoo.bsky.social @drpeedell.bsky.social
Updates the congress on the new #ESTRO guidelines in this area
@drjnaidoo.bsky.social @drpeedell.bsky.social
Follow-up after lung cancer treatment…when, who, where….?
Follow-up after lung cancer treatment…when, who, where….?
Brilliant show, amazing Irish talent and outstanding direction by Lia Mullan
Such a really enjoyable evening! 🎶👏👏👏
Brilliant show, amazing Irish talent and outstanding direction by Lia Mullan
Such a really enjoyable evening! 🎶👏👏👏
Chinese study in patients with EGFR positive oligo-organ metastatic #NSCLC. TKI plus RT group received 60Gy to primary and positive LNs. RT to metastases determined by clinicians.
Median OS was 26.2 months and 34.4 months (RT)
Chinese study in patients with EGFR positive oligo-organ metastatic #NSCLC. TKI plus RT group received 60Gy to primary and positive LNs. RT to metastases determined by clinicians.
Median OS was 26.2 months and 34.4 months (RT)
In my work I am keen that we care for the person and not just the disease #UnitedbyUnique.
In my work I am keen that we care for the person and not just the disease #UnitedbyUnique.
Wishing colleagues at #QUB continued success in 2025 as you lead Northern Ireland’s academic, research and education sectors.
#HappyNewYear
Wishing colleagues at #QUB continued success in 2025 as you lead Northern Ireland’s academic, research and education sectors.
#HappyNewYear
Michelle, I was trying to be good this week…🙈….trying desperately to avoid doing a Tim Tam slam…
@elizabethforde.bsky.social
Michelle, I was trying to be good this week…🙈….trying desperately to avoid doing a Tim Tam slam…
@elizabethforde.bsky.social
3 worthy finalists in Caitriona, Pauline and Moya with 4 very tasty creations, but who will win?
@charles2405.bsky.social
#GBBO
#StayTuned
3 worthy finalists in Caitriona, Pauline and Moya with 4 very tasty creations, but who will win?
@charles2405.bsky.social
#GBBO
#StayTuned
Highlights the improvements in Prostate Ca #radiotherapy
✅ Non-invasive
✅ painless treatment
✅ As few fractions as possible
✅ Put the dose where it matters
✅ few side effects
Highlights the improvements in Prostate Ca #radiotherapy
✅ Non-invasive
✅ painless treatment
✅ As few fractions as possible
✅ Put the dose where it matters
✅ few side effects
Is the UK SABR meeting ready for guest keynote speaker Prof Shankar Siva from @petermaccc.bsky.social ?
Stay tuned!
@alison-tree.bsky.social @drpeedell.bsky.social
#RadOnc
Is the UK SABR meeting ready for guest keynote speaker Prof Shankar Siva from @petermaccc.bsky.social ?
Stay tuned!
@alison-tree.bsky.social @drpeedell.bsky.social
#RadOnc
Lots of great discussion, reflection, ambition on how we continune to improve our ☘️cancer trials infrastructure.
Lots of great discussion, reflection, ambition on how we continune to improve our ☘️cancer trials infrastructure.
Also highlights that clinical trials are essential for high quality routine care
@EmerHigginsTD @shanemoynihan @DenisNaughten @DaithiDoolan
Also highlights that clinical trials are essential for high quality routine care
@EmerHigginsTD @shanemoynihan @DenisNaughten @DaithiDoolan
@CotterSeamus makes an impassioned plea on the need to have trials available for patients
#GeneralElection
@CotterSeamus makes an impassioned plea on the need to have trials available for patients
#GeneralElection